Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential


     Related Videos
HHMI s Stem Cells - Coaxing Embryonic Stem Cells
What are stem cells?
  • What are stem cells?

  • Max Wicha, MD, Director of the UM Comprehensive Cancer Center explains what stem cells are and what ...

Developing Egg Cells
  • Developing Egg Cells

  • occur very rapidly. Cells divide every thirty minutes. This timing is very precise. Egg cells that h...

Hair Cells II
  • Hair Cells II

  • This video demonstrates the flexibility of a single hair cell. This video is from: Essential Cell Bi...

Hair Cells I
  • Hair Cells I

  • This video describes how hair cells work to help us hear sound. This video is from: Essential Cell B...


     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: (1061)   Date: (06-01-09)   Pages: ()
    • Author:  Fazel SS  Angoulvant D  Butany J  Weisel RD  Li RK.  

    • Abstract:  Division of Cardiac Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • Mesenchymal Stem Cells Have New Cell Culture Environment
              BILLERICA, Mass., Feb. 8, 2012 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Mosaic™ Mesenchymal Stem Cell Serum-Free (hMSC ...
            • Stemedica Granted U.S. Patent for Cellular Scaffold
              Stemedica has been issued U.S. Patent #8,105,380 by the United States Patent and Trademark Office. This broad-based patent covers the combination of scaffolds with stem cells derived from ectodermal and mesenchymal tissue. These multi-stem cell products address need in the $12.5 billion wound care field.San Diego, CA (PRWEB) February 15, 2012 Stemedica Cell Technologies, Inc. (Stemedica), a ...
            • Neurologic improvement detected in rats receiving stem cell transplant
              Researchers report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain. The study was designed to have the rat's brain damage mimic brain injury in infants with very low birth weight.
            • Early MSC transplantation can help repair neonatal brain damage
              In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's ...
            • Cryo-Cell International, Inc. Announces Material Transfer Agreement with Stanford University
              Collaboration will evaluate menstrual stem cells for future potential diabetes therapyOldsmar, Fla (PRWEB) February 07, 2012 Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) and Stanford University announced signing a material transfer agreement to test the efficacy of mesenchymal-like stem cells derived from menstrual blood (MenSCs) in a model of pancreatic islet ...
            • Bone Repair Stem Cell Breakthrough Shows Promise
              According to a study published in the February issue of the STEM CELL Translational Medicine Journal , a world-first technique for generating adult stem cells (mesenchymal stem cells [MSCs]) has been developed by researchers at the University of Queensland. This new method can be used to repair bone and possibly other organs, and will considerably affect individuals suffering from a variety of ...
            • IntelliCell Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells
              IntelliCell BioSciences, Inc. ; or the , December 27, 2010 IntelliCell filed its patent application with the US Patent office that will claim priority to its provisional US patent serial #61/427, 221 that was filed on December 27, 2010.
            • Exercise triggers stem cells in muscle
              ( University of Illinois at Urbana-Champaign ) University of Illinois researchers determined that an adult stem cell present in muscle is responsive to exercise, a discovery that may provide a link between exercise and muscle health. The findings could lead to new therapeutic techniques using these cells to rehabilitate injured muscle and prevent or restore muscle loss with age.
            • Muscle Stem Cells Activated By Exercise
              University of Illinois researchers determined that an adult stem cell present in muscle is responsive to exercise, a discovery that may provide a link between exercise and muscle health. The findings could lead to new therapeutic techniques using these cells to rehabilitate injured muscle and prevent or restore muscle loss with age. Mesenchymal stem cells (MSCs) in skeletal muscle have been ...
            • Experimental Neurology Journal: BrainStorm's NurOwn™ Stem Cell Technology Shows Promise for Treating Huntington's ...
              BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell technologies and therapeutics, announced today that the prestigious Experimental Neurology Journal, published an article indicating that preclinical studies using cells that underwent treatment with Brainstorm’s NurOwn™ technology show promise in an animal model of Huntington’s disease.

                 Related on Wikipedia




























               

              Powered free by PHPmotion